New radiotherapy approaches in locally advanced non-small cell lung cancer

European Journal of Cancer

Volumn 50, Issue 3, 2014, Pages 525-534

  Christodoulou, Marianna ^a   Bayman, Neil ^b   McCloskey, Paula ^b   Rowbottom, Carl ^b   Faivre Finn, Corinne ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Altered fractionation; Dose escalation; Image guided radiation therapy; Intensity modulated radiotherapy; Lung cancer; Non small cell lung cancer; Personalised radiotherapy; Proton beam therapy; Radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; MOLECULARLY TARGETED THERAPY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE ESCALATION; RADIATION DOSE FRACTIONATION; REVIEW;

ALTERED FRACTIONATION; DOSE ESCALATION; IMAGE-GUIDED RADIATION THERAPY; INTENSITY MODULATED RADIOTHERAPY; LUNG CANCER; NON-SMALL CELL LUNG CANCER; PERSONALISED RADIOTHERAPY; PROTON BEAM THERAPY; RADIOTHERAPY;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LUNG NEOPLASMS; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 84893687981     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.11.027     Document Type: Review

References (62)

1. E. Lim, D. Baldwin, and M. Beckles et al. Guidelines on the radical management of patients with lung cancer Thorax 65 Suppl. 3 2010 iii1 iii27
2. L. Crinò, W. Weder, J. Van Meerbeeck, and E. Felip Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 Suppl. 5 2010 v103 v115
3. D.D. Ruysscher, A. Botterweck, and M. Dirx et al. Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study Ann Oncol 20 1 2009 98 102
4. J. Helbrow, F. MacNicoll, N. Bayman, and C. Faivre-Finn Concurrent chemoradiotherapy for locally advanced, unresectable non-small cell lung cancer: a UK survey of current practice Clin Oncol (R Coll Radiol) 24 8 2012 e127
5. T. Le Chevalier, R. Arriagada, and E. Quoix et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients J Natl Cancer Inst 83 6 1991 417 423
6. A. Aupérin, C. Le Péchoux, and E. Rolland et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 13 2010 2181 2190
7. M. Machtay, R. Paulus, and J. Moughan et al. Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma: a Radiation Therapy Oncology Group analysis J Thorac Oncol 7 4 2012 716 722
8. H. Onishi, H. Shirato, and Y. Nagata et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 7 Suppl. 3 2007 S94 S100
9. S. Walters, C. Maringe, and M.P. Coleman et al. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007 Thorax 68 6 2013 551 564
10. M.K. Martel, R.K. Ten Haken, and M.B. Hazuka et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients Lung Cancer 24 1 1999 31 37
11. J.D. Bradley, K. Bae, and M.V. Graham et al. Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117 J Clin Oncol 28 14 2010 2475 2480
12. S.E. Schild, W.L. McGinnis, and D. Graham et al. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer Int J Radiat Oncol Biol Phys 65 4 2006 1106 1111
13. M.A. Socinski, A.W. Blackstock, and J.A. Bogart et al. Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105 J Clin Oncol 26 15 2008 2457 2463
14. M.A. Socinski, J.G. Rosenman, and J. Halle et al. Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified phase I/II trial Cancer 92 5 2001 1213 1223
15. J.D. Bradley, R. Paulus, and R. Komaki et al. A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: results on radiation dose in RTOG 0617 J Clin Oncol 31 15 2013 7501
16. J.D. Cox Are the results of RTOG 0617 mysterious? Int J Radiat Oncol Biol Phys 82 3 2012 1042 1044
17. M. Saunders, S. Dische, A. Barrett, A. Harvey, D. Gibson, and M. Parmar Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee Lancet 350 9072 1997 161 165
18. M. Baumann, T. Herrmann, and R. Koch et al. Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated- accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC) Radiother Oncol 100 1 2011 76 85
19. A. Mauguen, C. Le Péchoux, and M.I. Saunders et al. Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis J Clin Oncol 30 22 2012 2788 2797
20. J.G. Ravenel Evidence-based imaging in lung cancer: a systematic review J Thorac Imaging 27 5 2012 315 324
21. D. De Ruysscher, U. Nestle, R. Jeraj, and M. Macmanus PET scans in radiotherapy planning of lung cancer Lung Cancer 75 2 2012 141 145
22. D. De Ruysscher, J. Belderbos, and B. Reymen et al. State of the art radiation therapy for lung cancer 2012: a glimpse of the future Clin Lung Cancer 14 2 2013 89 95
23. W. Van Elmpt, D. De Ruysscher, and A. Van der Salm et al. The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer Radiother Oncol 104 1 2012 67 71
24. Y. Lievens, A. Nulens, and M.A. Gaber et al. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study Int J Radiat Oncol Biol Phys 80 1 2011 306 313
25. J.Y. Chang, L. Dong, and H. Liu et al. Image-guided radiation therapy for non-small cell lung cancer J Thorac Oncol 3 2 2008 177 186
26. M. Guckenberger, J. Wilbert, and A. Richter et al. Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer Int J Radiat Oncol Biol Phys 79 3 2011 901 908
27. G. Lim, A. Bezjak, and J. Higgins et al. Tumor regression and positional changes in non-small cell lung cancer during radical radiotherapy J Thorac Oncol 6 3 2011 531 536
28. H.H. Liu, X. Wang, and L. Dong et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 58 4 2004 1268 1279
29. H. Murshed, H.H. Liu, and Z. Liao et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer Int J Radiat Oncol Biol Phys 58 4 2004 1258 1267
30. J.A. Christian, J.L. Bedford, S. Webb, and M. Brada Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 67 3 2007 735 741
31. I.S. Grills, D. Yan, A.A. Martinez, F.A. Vicini, J.W. Wong, and L.L. Kestin Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation Int J Radiat Oncol Biol Phys 57 3 2003 875 890
32. R.K. Shrimali, G.J. Webster, and L.W. Lee et al. A paradigm shift IMRT enables radical treatment in locally advanced lung cancer patients who would have been treated with palliative intent with 3D conformal radiotherapy (3D CRT) Lung Cancer 71 1 2011 S34
33. Z.X. Liao, R.R. Komaki, and H.D. Thames Jr et al. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy Int J Radiat Oncol Biol Phys 76 3 2010 775 781
34. S.S. Yom, Z. Liao, and H.H. Liu et al. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 68 1 2007 94 102
35. Z.-Q. Jiang, K. Yang, and R. Komaki et al. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience Int J Radiat Oncol Biol Phys 83 1 2012 332 339
36. A. Bezjak, R.B. Rumble, G. Rodrigues, A. Hope, and P. Warde Members of the IMRT indications expert panel. Intensity-modulated radiotherapy in the treatment of lung cancer Clin Oncol (R Coll Radiol) 24 7 2012 508 520
37. T. Bortfeld, K. Jokivarsi, M. Goitein, J. Kung, and S.B. Jiang Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation Phys Med Biol 47 13 2002 2203 2220
38. S.B. Jiang, C. Pope, K.M. Al Jarrah, J.H. Kung, T. Bortfeld, and G.T.Y. Chen An experimental investigation on intra-fractional organ motion effects in lung IMRT treatments Phys Med Biol 48 12 2003 1773 1784
39. R.I. Berbeco, C.J. Pope, and S.B. Jiang Measurement of the interplay effect in lung IMRT treatment using EDR2 films J Appl Clin Med Phys 7 4 2006 33 42
40. L.E. Court, J. Seco, and X.-Q. Lu et al. Use of a realistic breathing lung phantom to evaluate dose delivery errors Med Phys 37 11 2010 5850 5857
41. J.Y. Chang, X. Zhang, and X. Wang et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 65 4 2006 1087 1096
42. C.H. Lee, D. Tait, A.E. Nahum, and S. Webb Comparison of proton therapy and conformal X-ray therapy in non-small cell lung cancer (NSCLC) Br J Radiol 72 863 1999 1078 1084
43. R.C. Nichols, S.N. Huh, and R.H. Henderson et al. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study Clin Lung Cancer 12 4 2011 252 257
44. D.A. Bush, J.D. Slater, B.B. Shin, G. Cheek, D.W. Miller, and J.M. Slater Hypofractionated proton beam radiotherapy for stage I lung cancer Chest 126 4 2004 1198 1203
45. K. Nihei, T. Ogino, S. Ishikura, and H. Nishimura High-dose proton beam therapy for Stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 65 1 2006 107 111
46. H. Iwata, M. Murakami, and Y. Demizu et al. High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer Cancer 116 10 2010 2476 2485
47. J.Y. Chang, R. Komaki, and H.Y. Wen et al. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer Int J Radiat Oncol Biol Phys 80 5 2011 1350 1357
48. M. Pijls-Johannesma, J.P.C. Grutters, P. Lambin, and D.D. Ruysscher Particle therapy in lung cancer: where do we stand? Cancer Treat Rev 34 3 2008 259 267
49. Y. Oshiro, M. Mizumoto, and T. Okumura et al. Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer J Thorac Oncol 7 2 2012 370 375
50. H. Nakayama, H. Satoh, and S. Sugahara et al. Proton beam therapy of Stage II and III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 81 4 2011 979 984
51. S. Sejpal, R. Komaki, and A. Tsao et al. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer Cancer 117 13 2011 3004 3013
52. J.Y. Chang, R. Komaki, and C. Lu et al. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer Cancer 117 20 2011 4707 4713
53. H.D. Skinner, and R. Komaki Proton radiotherapy in the treatment of lung cancer Transl Cancer Res 1 4 2012 264 270
54. Z. Liao, S.H. Lin, and J.D. Cox Status of particle therapy for lung cancer Acta Oncol 50 6 2011 745 756
55. R. Mohan, X. Zhang, and J. Matney et al. IMRT vs. passively scattered proton therapy (PSPT) for locally advanced non-small cell lung CA (LA NSCLC) randomized trial - is there equipoise? Int J Radiat Oncol Biol Phys 78 3 2010 S201 S202
56. C.A. Perez, M. Bauer, S. Edelstein, B.W. Gillespie, and R. Birch Impact of tumor control on survival in carcinoma of the lung treated with irradiation Int J Radiat Oncol Biol Phys 12 4 1986 539 547
57. A. Van Baardwijk, G. Bosmans, and L. Boersma et al. Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility study Int J Radiat Oncol Biol Phys 71 5 2008 1394 1401
58. A. Van Baardwijk, S. Wanders, and L. Boersma et al. Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer J Clin Oncol 28 8 2010 1380 1386
59. A. Van Baardwijk, B. Reymen, and S. Wanders et al. Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer Eur J Cancer 48 15 2012 2339 2346
60. P.K. Koh, C. Faivre-Finn, F.H. Blackhall, and D. De Ruysscher Targeted agents in non-small cell lung cancer (NSCLC): clinical developments and rationale for the combination with thoracic radiotherapy Cancer Treat Rev 38 6 2012 626 640
61. D.R. Spigel, J.D. Hainsworth, and D.A. Yardley et al. Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab J Clin Oncol 28 1 2010 43 48
62. T. Hoang, S.E. Dahlberg, and J.H. Schiller et al. Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer: the ECOG 3598 study J Clin Oncol 30 6 2012 616 622